Catégorie
Deferoxamine
Numéro CAS
Deferoxamine STD-70-51-9;138-14-7(Mesylate): IMP-A-1884272-02-9
Formule moléculaire
Deferoxamine STD-C25H48N6O8: IMP-A-C24H46N6O8
Masse moléculaire
Deferoxamine STD-560.68: IMP-A-546.67
Synonyme

Deferoxamine STD-N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide; N1-(5-Aminopentyl)-N1-hydroxy-N4-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]butanediamide; N-[5-[3-[(5-Aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]propionohydroxamic Acid;N1-(5-Aminopentyl)-N1-hydroxy-N4-(5-(N-hydroxy-4-((5-(N-hydroxyacetamido)pentyl)amino)-4-oxobutanamido)pentyl)succinamide; Deferoxamine B; Deferoxamine; Deferrioxamine B; Desferal mesylate; Desferrioxamine B; Desferrioxamine

Deferoxamine EP-Impurity-A-N-[5-[acetyl(hydroxy)amino]pentyl]-N'-[5-[[4-[4-aminobutyl(hydroxy)amino]-4-oxobutanoyl]amino]pentyl]-N'-hydroxybutanediamide; N1-[5-(4-[(4-Aminobutyl)(hydroxy)amino]-4-oxobutanamido)pentyl]-N1-hydroxy-N4-[5-(N-hydroxyacetamido)pentyl]butanediamide

slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Deferoxamine for System Suitability CRS is a certified reference standard used in analytical laboratories to verify that an HPLC, GC, or other analytical system is performing correctly. It ensures proper peak resolution, retention time, and overall system reliability, helping validate analytical methods and maintain consistent quality control when testing deferoxamine in pharmaceutical formulations.